FIELD: medicine.
SUBSTANCE: the suggested innovation deals with introducing the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl](3R,5S)-3.5-dihydroxy-hept-6-enic acid (rosuvastatin) or its pharmaceutically acceptable salt that enables to achieve curative effect of applying rosuvastatin only.
EFFECT: higher efficiency of application.
20 cl, 1 dwg, 3 ex, 1 tbl
Title |
Year |
Author |
Number |
APPLICATION OF 3-HYDROXY-3-METHTYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS IN PRODUCING MEDICINAL AGENT FOR TREATMENT OF DIABETIC NEUROPATHY |
2000 |
- Kehmeron Norman Judzhin
- Kotter Mehri Ehnn
|
RU2239456C2 |
METHODS OF TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) |
2015 |
- Baccara-Dinet, Marie
- Hanotin, Corinne
- Bessac, Laurence
- Chaudhari, Umesh
- Pordy, Robert
- Sasiela, William
- Schwemmer Gipe, Daniel, A.
|
RU2735521C2 |
MEDICINAL COMBINATION COMPRISING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND INHIBITOR, INDUCTOR OR SUBSTRATE FOR P-450 3A4 ISOZYME |
2000 |
- Raza Ali
- Pirs Dzhon Stjuart
- Khatchinson Khauard Dzherard
- Shnek Dennis
- Baba Takakhiko
- Touti Akira
- Jamaguti Jositaka
|
RU2233162C2 |
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS |
2012 |
- Anoten Korinn
- Bessak Lorans
- Chaudkhari Umesh
|
RU2603481C2 |
METHODS OF TREATING PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR DISEASES HAVING HYPERCHOLESTEROLEMIA |
2015 |
- Hanotin, Corinne
- Bessac, Laurence
- Chaudhari, Umesh
- Pordy, Robert
- Schwemmer Gipe, Daniel, A.
|
RU2723018C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO HUMAN PCSK9 |
2012 |
- Anoten Korinn
- Bessak Lorans
- Chaudkhari Umesh
|
RU2604139C2 |
FIXED COMBINATIONS AND COMPOUNDS CONTAINING ETC-1002 AND EZETIMIBE, AND METHOD FOR TREATING OR REDUCING THE RISK OF DEVELOPING A CARDIOVASCULAR DISEASE |
2016 |
- Newton, Roger Schofield
- Rosenberg, Noah Laban
- Macdougall, Diane Elaine
|
RU2766085C2 |
FIXED COMBINATIONS AND COMPOSITIONS CONTAINING ETC1002 AND ONE OR MORE STATINS, AND METHODS FOR TREATMENT OR REDUCTION IN RISK OF DEVELOPMENT OF CARDIOVASCULAR DISEASE |
2016 |
- Newton, Roger Schofield
- Rosenberg, Noah Laban
- Macdougall, Diane Elaine
|
RU2765218C2 |
CRYSTALLINE FORM OF CALCIUM SALT OF BIS-[(E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULPHONYL)AMINO]-PYRIMIDIN-5-YL](3R, 5S)-3, 5-DIHYDROXYHEPT-6-ENOIC ACID |
2004 |
- But Rebekka Dzhejn
- Sittern Piter Ehntoni
- Krabb Dzheffri Norman
- Khorberi Dzhon
- Dzhouns Dejvid Uin Kalvert
|
RU2363697C2 |
TREATING WITH ANTI-PCSK9 ANTIBODIES |
2012 |
|
RU2576034C2 |